SC35 Inhibitors

SC35 inhibitors are a class of chemical compounds that target a specific protein called SC35, which plays a crucial role in pre-mRNA splicing, a fundamental cellular process in eukaryotic organisms. Pre-mRNA splicing is the intricate process by which non-coding regions, known as introns, are removed from the precursor messenger RNA (pre-mRNA), while the coding regions, known as exons, are joined together to form mature mRNA molecules. This process is essential for gene expression and the production of functional proteins. SC35, also known as SRSF2 (serine/arginine-rich splicing factor 2), is a key member of the serine/arginine-rich (SR) protein family, which are essential splicing factors. SC35 inhibitors specifically target SC35 to modulate its activity, leading to alterations in splicing patterns and potentially influencing the expression of various genes.

The mechanism of action of SC35 inhibitors typically involves interfering with the binding of SC35 to pre-mRNA molecules, affecting its ability to recognize and splice intron-exon junctions accurately. By doing so, these inhibitors can disrupt the normal splicing process and lead to the generation of alternative mRNA isoforms, which may have different functional consequences. Researchers have been exploring SC35 inhibitors as valuable tools for studying splicing regulation and gaining insights into the intricate network of gene expression. Additionally, these compounds have the potential to be used in a range of research applications, including investigating the roles of specific genes and their alternative splicing variants in various cellular processes and diseases, thereby expanding our understanding of molecular biology and disease mechanisms.